Literatur
- 1
Bock C T, Tillmann H L, Torresi J. et al .
Selection of hepatitis B virus polymerase mutants with
enhanced replication by lamivudine treatment after liver
transplantation.
Gastroenterology.
2002;
122
264-273
- 2
Dienstag J L, Goldin R D, Heathcote E J. et al .
Histological outcome during long-term lamivudine
therapy.
Gastroenterology.
2003;
124
105-117
- 3
EASL international consensus conference on hepatitis
B .
Consensus statement.
J
Hepatol.
2003;
38
533-540
- 4
Fried M W, Shiffman M L, Reddy K R. et al .
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C
virus infection.
N Engl J
Med.
2002;
347
975-982
- 5
Hadziyannis S J, Cheinquer H, Morgan T. et al .
Peginterferon alfa-2a (40KD) (pegasys) in combination with
ribavirin (RBV): Efficacy and safety results from a phase III, randomized,
double-blind, multicentre study examining effect of duration of treatment and
RBV dose.
J
Hepatol.
2002;
36
S1
- 6
Hadziyannis S J. et al .
Adefovir dipivoxil for the treatment of hepatitis B e
antigen-negative chronic hepatitis B.
N Engl J
Med.
2003;
348
800-807
- 7
Jäckel E, Cornberg M, Wedemeyer H. et al .
Treatment of acute hepatitis C with interferon
alfa-2b.
N Engl J
Med.
2001;
345
1452-1457
- 8
Manesis E K, Hadziyannis S J.
Interferon alpha treatment and retreatment of hepatitis B e
antigen-negative chronic hepatitis
B.
Gastroenterology.
2001;
121
101-109
- 9
Manns M P. et al .
Peginterferon alfa-2b plus ribavirin compared with interferon
alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a
randomised
trial.
Lancet.
2001;
358
958-965
- 10
Marcellin P, Chang T T, Lim S G. et al .
Adefovir dipivoxil for the treatment of hepatitis B e
antigen-positive chronic hepatitis B.
N Engl J
Med.
2003;
348
808-816
- 11
McHutchison J G, Manns M P, Patel K. et al .
Adherence to combination therapy enhances sustained response
in genotype-1-infected patients with chronic hepatitis
C.
Gastroenterology.
2002;
123
1061-1069
- 12
Nafa S, Ahmed S, Tavan D. et al .
Early detection of viral resistance by determination of
hepatitis B virus polymerase mutations in patients treated by lamivudine for
chronic hepatitis
B.
Hepatology.
2000;
32
1078-1088
- 13
National Institutes of Health Consensus Development
Conference Statement .
Management of hepatitis C:
2002.
Hepatology.
2002;
36
S3-S20
- 14
Perrillo R, Schiff E, Yoshida E. et al .
Adefovir dipivoxil for the treatment of lamivudine-resistant
hepatitis B
mutants.
Hepatology.
2000;
32
129-134
- 15
Shiffman M L.
Retreatment of patients with chronic hepatitis
C.
Hepatology.
2002;
36
S128-134
- 16
Tillmann H L. et al .
Early lamivudine therapy may prevent liver failure in
patients with fulminant hepatitis
B.
Hepatology.
2002;
36
375A
- 17
Trautwein C, Manns M P.
Antivirale Therapie der
Virushepatitis.
Internist.
2001;
42
913-923
- 18
Wiese M. et al .
Low frequency of cirrhosis in a hepatitis C (genotype 1b)
single-source outbreak in
germany.
Hepatology.
2000;
32
91-96
Prof. Dr. C. Trautwein
Abteilung für Gastroenterologie, Hepatologie &
Endokrinologie, Medizinische Hochschule Hannover
Carl-Neuberg-Straße 1
30625 Hannover
Phone: 49/511/5326620
Fax: 49/511/5324896
Email: trautwein.christian@mh-hannover.de
